# Methotrexate and Cytosine in Adult Langerhans Cell Histiocytosis

> **NCT02389400** · PHASE2 · COMPLETED · sponsor: **Peking Union Medical College Hospital** · enrollment: 43 (actual)

## Conditions studied

- Langerhans Cell Histiocytosis

## Interventions

- **DRUG:** methotrexate

## Key facts

- **NCT ID:** NCT02389400
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2017-09
- **Final completion:** 2017-09
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2018-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02389400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02389400, "Methotrexate and Cytosine in Adult Langerhans Cell Histiocytosis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02389400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*